PSMA antigen vaccine (Progenics)

N/A

Report date: 2025/02/11 10:46:13

Base Information

Drug NamePSMA antigen vaccine (Progenics)
Drug Alias NameRecombinant soluble PSMA protein vaccine (Progenics)Prostate cancer subunit vaccine (Progenics)rsPSMA (Progenics)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMemorial Sloan Kettering Cancer Center
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A